Molecular Partners is based in Zürich-Schlieren, Switzerland. It has raised $65M in total funding.
Molecular Partners funding overview
Molecular Partners is based in Zürich-Schlieren, Switzerland. Molecular Partners has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Molecular Partners runs through 2016; nothing later has been disclosed. Investors on record include Essex Woodlands Health Ventures, Index Ventures, Johnson & Johnson Development Corporation, BB Biotech Ventures, Endeavour. 5 distinct backers are named across the disclosed rounds.
Molecular Partners at a glance
Total raised
$65M
Latest round date
April 2016
Headquarters
Zürich-Schlieren, Switzerland
Notable investors
Essex Woodlands Health Ventures, Index Ventures, Johnson & Johnson Development Corporation, BB Biotech Ventures, Endeavour
Frequently asked about Molecular Partners funding
How much has Molecular Partners raised?
Molecular Partners has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Molecular Partners?
Essex Woodlands Health Ventures, Index Ventures, Johnson & Johnson Development Corporation, BB Biotech Ventures, Endeavour are named among the investors backing Molecular Partners.
What was the latest Molecular Partners funding round?
No round stage has been disclosed for Molecular Partners.
Where is Molecular Partners based?
Molecular Partners is based in Zürich-Schlieren, Switzerland.
When did Molecular Partners last raise?
The last disclosed Molecular Partners round closed in April 2016.
We update the Molecular Partners record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Zürich-Schlieren and their backers are listed below.
